BTLA anticorps (C-Term)
-
- Antigène Voir toutes BTLA Anticorps
- BTLA (B and T Lymphocyte Associated (BTLA))
-
Épitope
- C-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp BTLA est non-conjugé
-
Application
- Western Blotting (WB), ELISA
- Réactivité croisée
- Humain
- Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogène
- Synthesized peptide derived from C-terminal of Human BTLA.
- Isotype
- IgG
- Top Product
- Discover our top product BTLA Anticorps primaire
-
-
- Indications d'application
- WB:1:500-1:3000,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- BTLA (B and T Lymphocyte Associated (BTLA))
- Autre désignation
- BTLA (BTLA Produits)
- Synonymes
- anticorps BTLA, anticorps BTLA1, anticorps CD272, anticorps A630002H24, anticorps B and T lymphocyte associated, anticorps BTLA, anticorps Btla
- Sujet
-
Background: Lymphocyte inhibitory receptor which inhibits lymphocytes during immune response.
Watanabe N., Nat. Immunol. 4:670-679(2003).
Mao Y., Submitted (APR-2004) to the EMBL/GenBank/DDBJ databases.
Oaks M.K., Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.Aliases: B and T lymphocyte associated protein antibody, B and T lymphocyte attenuator antibody, B and T lymphocyte associated antibody, B- and T-lymphocyte attenuator antibody, B- and T-lymphocyte-associated protein antibody, BTLA antibody, BTLA_HUMAN antibody, BTLA1 antibody, CD272 antibody, CD272 antigen antibody, FLJ16065 antibody, MGC129743 antibody
- UniProt
- Q7Z6A9
- Pathways
- Cancer Immune Checkpoints
-